Aktive Positionen von Daniel Gooding
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NUFORMIX PLC | Direktor/Vorstandsmitglied | - | - |
| Gründer | 01.01.2008 | - | |
| Vorstandsvorsitzender | 01.01.2008 | 22.06.2020 | |
| Vorsitzender | 05.02.2020 | - |
Karriereverlauf von Daniel Gooding
Ehemalige bekannte Positionen von Daniel Gooding
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Nuformix Technologies Ltd.
 Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | 23.10.2007 | 01.06.2020 |
| Vorstandsvorsitzender | 23.10.2007 | 01.06.2020 | |
| Gründer | 23.10.2007 | 01.06.2020 |
Ausbildung von Daniel Gooding
| University of Leeds | Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 4 |
Operativ
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NUFORMIX PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Nuformix Technologies Ltd.
Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Daniel Gooding
- Erfahrung
